Ricardo Abreu, a UFC fighter with two appearances in the promotion is currently serving a two year suspension by USADA for a failed drug test (suspension ends 7/1/18), has been notified of a potential second violation by USADA.
Abreu failed an out of competition drug test in July 2016 for metabolites from anabolic steroids, this new potential failed drug test was from another out of competition collected by USADA on December of 2016, it’s unknown what Abreu may have failed for this time around.
The UFC issued the following statement:
“The UFC organization was formally notified today that the U.S. Anti-Doping Agency (USADA) has informed Ricardo Abreu of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection taken on December 21, 2016.
“Abreu is currently serving a two-year suspension under the UFC Anti-Doping Program, after the anabolic steroid metabolites 19-norandrosterone (19-NA) and 19-noretiocholanolone were detected in a sample collected from Abreu on June 3, 2016. Under his current suspension, Abreu is not eligible to return to competition until July 1, 2018.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed.
“Consistent with all previous potential anti-doping violations, additional information or UFC statements will be provided at the appropriate time as the process moves forward.”
Abreu hasn’t competed since UFC Fight Night 68 in June 2015, where he suffered a split decision loss to Jake Collier.
